YR
Yasmeen Rahimi Piper Sandler Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
26
Protagonist Therapeutics
PTGX
$3.77B
| $60.53 | $35 |
42%
downside
| Overweight | 2 years ago |
|
27
Cytokinetics
CYTK
$6.34B
| $53.01 | $72 |
36%
upside
| Overweight | 3 years ago |
|
28
89bio
ETNB
$1.32B
| $8.87 | $19 |
114%
upside
| Overweight | 3 years ago |
|
|
AMRN
29
Amarin Corp
AMRN
$317M
| $15.33 | $420 |
2,640%
upside
| Overweight | 5 years ago |
|
30
Arcturus Therapeutics
ARCT
$485M
| $17.85 | $77 |
331%
upside
| Overweight | 5 years ago |
|
31
Mirum Pharmaceuticals
MIRM
$3.82B
| $76.06 | $77 |
1%
upside
| Overweight | 5 years ago |
|